CORDIS · 279277 · FP7
PRIORITY Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria
Coordinator: REGION HOVEDSTADEN (DK)
Patients with diabetes are at risk of developing diabetic nephropathy, which will ultimately result in the requirement for renal replacement therapy and is also associated with high cardiovascular morbidity and mortality. Detection of low concentrations of albuminuria in urine (microalbuminuria) is the current clinical standard for detecting those at significant risk and targeting preventive treatment. However, albuminuria is of low specificity at early stages of disease, and of considerable biological variability, hence a poor predictor at early stages of disease. In two independent studies …
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €6.0M awarded to the consortium. The project runs over approximately 7 years from 2012-01-01 to 2018-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from DK
see all →- GreenHyScale — 100 MW Green hydrogen production in a replicable and scalable industrial hosting environment101036935 · H2020 · €30.0M
- COMPARE — COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe643476 · H2020 · €20.8M
- ARCHIMEDES — Achieving Real Change with Innovative Transport Measures Demonstrating Energy Savings218940 · FP7 · €16.0M
- Green2Ice — When was Greenland ‘green’? – Perspectives from basal ice and sediments from ice cores.101072180 · HORIZON · €13.9M
- METRIQS — Metamaterial Interfaces for Quantum Electronics101167432 · HORIZON · €13.3M
- SUBNORDICA — Beyond submerged landscapes - defining human response to postglacial sea-level rise and climate change101119164 · HORIZON · €13.2M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-FP funding scheme.
- What is the EU contribution?
- The European Commission contributes €6.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by REGION HOVEDSTADEN (DK).
- What is the project timeline?
- The project runs from 2012-01-01 to 2018-12-31 — approximately 7 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 279277.